Article
Understanding various index components can help you evaluate your investmentperformance
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Money Matters: How to invest during rising inflation
Money Matters: Informing your perspective on the bear market
Urology Times Money Matters: What you must do to survive down markets
Urology Times Money Matters: Annuity myths
UT Money Matters: Are REITs right for your portfolio?
UT Money Matters: Roth IRA conversions
Health Canada approves perioperative durvalumab plus chemo for MIBC
Study offers insights into optimal patient selection for HIFU in prostate cancer
FDA accepts NDA for new formulation of piflufolastat F 18 in prostate cancer
First-line disitamab vedotin plus toripalimab under review in China for la/mUC